Table 2. Detailed clinical... | American Society of Hematology

Table 2.

Detailed clinical characteristics and hematopoietic reconstitution following CBT

Patient no.	Disease	Patient age, mo	Cells infused, × 10⁷/kg	Time to PMN recovery, d	Time to PLT recovery, d	Time from CBT, mo	CFCs, per 2 × 10⁴	LTC-ICs, per 10⁶
1	ALL	48	3	26	42	7	24	8
2	ALL	52	3.8	24	48	16	20	9.4
3	Thal	73	4.8	39	75	7	56	15.4
4	SCID	3	18	21	54	9	15	3.4
5	ALL	61	4.5	28	100	17	20	5.4
6	Thal	180	1.9	21	44	12	39	10
7	Thal	96	3.6	20	30	13	7	7.2
8	ALL	93	2.7	24	47	12	20	11.6
9	AML	9	9	17	55	8	10	8.4
10	Thal	71	5.7	26	46	13	13	7.2
11	Thal	40	6	18	42	6	45	5.4
12	ALL	66	2.7	16	68	16	50	12.6
Median		63	3.7^*	22.5†	47.5‡	12§	20∥	8.2¶
Range		3-180	1.9-18	16-39	30-100	6-17	7-56	3.4-15.4

Patient no.	Disease	Patient age, mo	Cells infused, × 10⁷/kg	Time to PMN recovery, d	Time to PLT recovery, d	Time from CBT, mo	CFCs, per 2 × 10⁴	LTC-ICs, per 10⁶
1	ALL	48	3	26	42	7	24	8
2	ALL	52	3.8	24	48	16	20	9.4
3	Thal	73	4.8	39	75	7	56	15.4
4	SCID	3	18	21	54	9	15	3.4
5	ALL	61	4.5	28	100	17	20	5.4
6	Thal	180	1.9	21	44	12	39	10
7	Thal	96	3.6	20	30	13	7	7.2
8	ALL	93	2.7	24	47	12	20	11.6
9	AML	9	9	17	55	8	10	8.4
10	Thal	71	5.7	26	46	13	13	7.2
11	Thal	40	6	18	42	6	45	5.4
12	ALL	66	2.7	16	68	16	50	12.6
Median		63	3.7^*	22.5†	47.5‡	12§	20∥	8.2¶
Range		3-180	1.9-18	16-39	30-100	6-17	7-56	3.4-15.4

ALL indicates acute lymphoblastic leukemia; Thal, thalassemia; and AML, acute myelogenous leukemia. Other abbreviations are explained in the footnote to Table 1.

P = .0001

†

P = .0002

‡

P = .0007

P = NS

∥

P = .007

P = .001

View Large

This Feature Is Available To Subscribers Only